Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Elutia Inc ELUT

Healthcare Biotechnology
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Device Protection, Women’s Health and Cardiovascular markets. These products are primarily sold to healthcare providers or commercial partners. In Device Protection, it sells CanGaroo, a biological envelope, that is indicated for use... see more

Recent & Breaking News (NDAQ:ELUT)

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

GlobeNewswire April 24, 2024

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

GlobeNewswire March 7, 2024

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

GlobeNewswire February 22, 2024

Elutia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire January 10, 2024

Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance

GlobeNewswire December 18, 2023

Elutia Reports 26% Year-Over-Year Sales Growth of Proprietary Products and Strengthened Balance Sheet in Third Quarter 2023 Financial Results

GlobeNewswire November 13, 2023

Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

GlobeNewswire November 9, 2023

Elutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023

GlobeNewswire November 6, 2023

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

PR Newswire October 18, 2023

Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference

GlobeNewswire September 20, 2023

Elutia Announces Private Placement for Proceeds Up to $26 Million

GlobeNewswire September 19, 2023

Elutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million

GlobeNewswire September 18, 2023

Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire September 8, 2023

Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices

GlobeNewswire September 6, 2023

Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures

GlobeNewswire August 30, 2023

Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company

GlobeNewswire August 14, 2023

Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023

GlobeNewswire July 31, 2023

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

PR Newswire July 17, 2023

Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix Products

GlobeNewswire July 13, 2023

Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic Envelope

GlobeNewswire May 19, 2023